Literature DB >> 21238843

Prognostic factors in patients with buccal squamous cell carcinoma: 10-year experience.

Jih-Chuan Jan1, Wu-Huei Hsu, Shih-An Liu, Yong-Kie Wong, Chiu-Kwan Poon, Rong-San Jiang, Jian-Sheng Jan, I-Fan Chen.   

Abstract

PURPOSE: Squamous cell carcinoma (SCC) of the buccal mucosa accounts for 23% to 37% of all intraoral cancer cases in Taiwan. Because of the high recurrence rate and invasive tumor behavior, the prognosis is generally poor. The aim of this study was to evaluate the prognostic significance of clinicopathologic factors on survival rates for patients with buccal SCC in a medical center in central Taiwan.
MATERIALS AND METHODS: Between March 1995 and December 2002, patients admitted to hospital and diagnosed as having buccal SCC were enrolled in the study. There were 415 patients (406 men and 9 women) 25 to 84 years old (mean age, 51.1 ± 11.4 years). The chart records were retrospectively reviewed. Relevant clinical features in each patient, such as primary tumor size, tumor stage, initial treatment modalities, surgical margin status, cervical nodal metastasis status, and histopathologic grade, were compared for survival analysis.
RESULTS: Three hundred ninety-four patients received surgical intervention. Univariate analysis of relevant prognostic factors showed that positive surgical margin, positive cervical nodal metastasis, positive extracapsular spread, larger tumor, and advanced tumor stage were associated with poor prognosis. Multivariate analysis identified the factors that independently influenced the survival rate as advanced stage disease (stage III: relative risk [RR], 3.09; P = .006; stage IV: RR, 4.64; P < .001), positive surgical margin (RR, 2.02; P = .001), and extracapsular spread of cervical lymph node metastasis (RR, 6.89; P < .001).
CONCLUSIONS: This study represents the largest series in the literature and highlights the importance of tumor stage, surgical margin status, and extracapsular spread of cervical nodal metastasis as the most important prognostic factors in patients with buccal SCC. Copyright Â
© 2011 American Association of Oral and Maxillofacial Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21238843     DOI: 10.1016/j.joms.2010.05.017

Source DB:  PubMed          Journal:  J Oral Maxillofac Surg        ISSN: 0278-2391            Impact factor:   1.895


  19 in total

1.  [Application of the nasolabial fold "smile" incision approach in posterior buccal cancer ablation].

Authors:  Tian Tian; Jie Chen; Ning Li; Long Huang; An-Jie Min; Xin-Qun Chen; Xin-Chun Jian; Can-Hua Jiang
Journal:  Hua Xi Kou Qiang Yi Xue Za Zhi       Date:  2019-12-01

2.  Guidelines for the Surgical Management of Oral Cancer: Korean Society of Thyroid-Head and Neck Surgery.

Authors:  Young-Hoon Joo; Jae-Keun Cho; Bon Seok Koo; Minsu Kwon; Seong Keun Kwon; Soon Young Kwon; Min-Su Kim; Jeong Kyu Kim; Heejin Kim; Innchul Nam; Jong-Lyel Roh; Young Min Park; Il-Seok Park; Jung Je Park; Sung-Chan Shin; Soon-Hyun Ahn; Seongjun Won; Chang Hwan Ryu; Tae Mi Yoon; Giljoon Lee; Doh Young Lee; Myung-Chul Lee; Joon Kyoo Lee; Jin Choon Lee; Jae-Yol Lim; Jae Won Chang; Jeon Yeob Jang; Man Ki Chung; Yuh-Seok Jung; Jae-Gu Cho; Yoon Seok Choi; Jeong-Seok Choi; Guk Haeng Lee; Phil-Sang Chung
Journal:  Clin Exp Otorhinolaryngol       Date:  2019-02-02       Impact factor: 3.372

3.  Influence of extracapsular nodal spread extent on prognosis of oral squamous cell carcinoma.

Authors:  Volkert B Wreesmann; Nora Katabi; Frank L Palmer; Pablo H Montero; Jocelyn C Migliacci; Mithat Gönen; Diane Carlson; Ian Ganly; Jatin P Shah; Ronald Ghossein; Snehal G Patel
Journal:  Head Neck       Date:  2015-10-30       Impact factor: 3.147

4.  p53 as a prognostic marker associated with the risk of mortality for oral squamous cell carcinoma.

Authors:  Tommaso Cutilli; Pietro Leocata; Vincenza Dolo; Emma Altobelli
Journal:  Oncol Lett       Date:  2016-06-16       Impact factor: 2.967

5.  Accuracy of Preoperative Imaging in Detecting Nodal Extracapsular Spread in Oral Cavity Squamous Cell Carcinoma.

Authors:  A H Aiken; S Poliashenko; J J Beitler; A Y Chen; K L Baugnon; A S Corey; K R Magliocca; P A Hudgins
Journal:  AJNR Am J Neuroradiol       Date:  2015-07-30       Impact factor: 3.825

6.  Epidemiological Features and Management of Oral Cancer Patients: Experience from a Single Private Comprehensive Cancer Care Center in the State of Odisha.

Authors:  Sanjoy Panda; Bibhuti Bishnu Nayak; N M L Manjunath; Krupasindhu Panda; Pramod Chandra Pathi
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2018-03-26

Review 7.  Spinal metastasis in head and neck cancer.

Authors:  Gregory M Trilling; Hyongyu Cho; Mohamed A Ugas; Samerah Saeed; Asia Katunda; Waseem Jerjes; Peter Giannoudis
Journal:  Head Neck Oncol       Date:  2012-06-20

8.  DNA methylome analysis identifies epigenetic silencing of FHIT as a determining factor for radiosensitivity in oral cancer: an outcome-predicting and treatment-implicating study.

Authors:  Hon-Yi Lin; Shih-Kai Hung; Moon-Sing Lee; Wen-Yen Chiou; Tze-Ta Huang; Chih-En Tseng; Liang-Yu Shih; Ru-Inn Lin; Jora M J Lin; Yi-Hui Lai; Chia-Bin Chang; Feng-Chun Hsu; Liang-Cheng Chen; Shiang-Jiun Tsai; Yu-Chieh Su; Szu-Chi Li; Hung-Chih Lai; Wen-Lin Hsu; Dai-Wei Liu; Chien-Kuo Tai; Shu-Fen Wu; Michael W Y Chan
Journal:  Oncotarget       Date:  2015-01-20

9.  Clinical Spectrum, Treatment and Relapse Patterns in 353 Patients with Squamous Cell Carcinoma of the Alveobuccal Complex Treated with a Curative Intent: A Retrospective Study.

Authors:  Nootan Kumar Shukla; S V Suryanarayana Deo; Ashish Jakhetiya; Manjunath Nml; Vishnubhatla Sreenivas; Sanjay Thulkar; Suman Bhasker; Atul Sharma
Journal:  J Maxillofac Oral Surg       Date:  2016-09-30

10.  Identifying the association rules between clinicopathologic factors and higher survival performance in operation-centric oral cancer patients using the Apriori algorithm.

Authors:  Jen-Yang Tang; Li-Yeh Chuang; Edward Hsi; Yu-Da Lin; Cheng-Hong Yang; Hsueh-Wei Chang
Journal:  Biomed Res Int       Date:  2013-07-25       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.